TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10368853

Group type: EXPERIMENTAL
Intervention: 500 lux light for 3 hours prior to awakening for 12 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0.1 lux light for 3 hours prior to awakening for 12 days (Placebo)
Number of subjects: 10
Study: 8683230

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg once daily
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Anastrozole 10 mg once daily
Number of subjects: 764

Group type: COMPARATOR
Intervention: Megestrol acetate 40 mg four times daily
Number of subjects: 764
Study: 1874767

Group type: EXPERIMENTAL
Intervention: Single dose of cefonicid (Group I)
Number of subjects: 1489

Group type: COMPARATOR
Intervention: Three doses of cefamandole (Group II)
Number of subjects: 1489

Group type: COMPARATOR
Intervention: Five doses of cefamandole (Group III)
Number of subjects: 1489
Study: 7097431

Group type: EXPERIMENTAL
Intervention: Behavioral conditioning with a urine alarm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy with imipramine hydrochloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clinical waiting list (control group)
Number of subjects: 0
Study: 31247461

Group type: EXPERIMENTAL
Intervention: AgFON substrate for SERS detection
Number of subjects: 0
Study: 27792112

Group type: EXPERIMENTAL
Intervention: Patient-controlled intermittent bolus epidural analgesia (PCIEA)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Patient-controlled continuous epidural analgesia (PCCEA)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 47
Study: 25938174

Group type: EXPERIMENTAL
Intervention: Banded group (BG)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Wire group (WG)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Banded group (BG) vs Wire group (WG)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Banded group (BG) and Wire group (WG)
Number of subjects: 9
Study: 24373641

Group type: EXPERIMENTAL
Intervention: DexNP (dexamethasone nanoparticle eye drops)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: DorzNP (dorzolamide nanoparticle eye drops)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Maxidex(®) (dexamethasone control)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Trusopt(®) (dorzolamide control)
Number of subjects: 6
Study: 23102530

Group type: EXPERIMENTAL
Intervention: Closed suction (CS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Open suction (OS)
Number of subjects: 20
Study: 19545211

Group type: EXPERIMENTAL
Intervention: Vaccine dose of 1 X 10(4) ffu
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Vaccine dose of 1 X 10(5) ffu
Number of subjects: 369

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369
Study: 17311544

Group type: EXPERIMENTAL
Intervention: Stable Xenon enhanced computed tomography (Xe‐CT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Group B (severely disabled, persistent vegetative state)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Group A (good recovery)
Number of subjects: 8
Study: 15302293

Group type: EXPERIMENTAL
Intervention: metformin 850 mg two times per day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: lifestyle modification plus metformin 850 mg two times per day
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: lifestyle modification plus placebo
Number of subjects: 38

Group type: COMPARATOR
Intervention: placebo alone
Number of subjects: 38
Study: 11591495

Group type: EXPERIMENTAL
Intervention: Nicotine (transdermal administration)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9643401

Group type: EXPERIMENTAL
Intervention: Routine adoption of HIV infection control guidelines during delivery (including protective glasses, impermeable garments, mask, sterile latex gloves, washing hands with detergent solution after using gloves, and collecting needles in suitable containers)
Number of subjects: 752

Group type: EXPERIMENTAL
Intervention: Use of latex gloves and collecting needles in suitable containers
Number of subjects: 752

Group type: EXPERIMENTAL
Intervention: Washing hands after using gloves
Number of subjects: 752

Group type: EXPERIMENTAL
Intervention: Protective impermeable garments, glasses, and mask
Number of subjects: 752
Study: 8036463

Group type: EXPERIMENTAL
Intervention: Topical metronidazole treatment (40-160 mg daily)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Topical metronidazole treatment
Number of subjects: 11
Study: 2657056

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 1194526

Group type: EXPERIMENTAL
Intervention: Provocation to anger with opportunity for retaliation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Provocation to anger with no opportunity to retaliate
Number of subjects: 60

Group type: COMPARATOR
Intervention: No provocation, no retaliation (control group)
Number of subjects: 60
Study: 31926854

Group type: EXPERIMENTAL
Intervention: Mineralocorticoid receptor antagonists (MRAs)
Number of subjects: 4396

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4396
Study: 31092443

Group type: EXPERIMENTAL
Intervention: S-1 (80 mg/m2) plus cisplatin (80 mg/m2) with bevacizumab (15 mg/kg) followed by maintenance with bevacizumab plus S-1 (SCB)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Pemetrexed (500 mg/m2) plus cisplatin (75 mg/m2) with bevacizumab (15 mg/kg) followed by maintenance with bevacizumab plus pemetrexed (PCB)
Number of subjects: 48
Study: 28079781

Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 138
Study: 25076118

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 23724543

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide at 15% with light activation (Lase Peroxide Lite)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide at 35% with light activation (Lase Peroxide Sensy)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide at 35% without light activation (Whitegold Office)
Number of subjects: 88
Study: 21777229

Group type: EXPERIMENTAL
Intervention: Prednisolone (40-60 mg/day for 2 weeks)
Number of subjects: 148
Study: 18423165

Group type: EXPERIMENTAL
Intervention: Escherichia coli isolates
Number of subjects: 3109

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin resistance
Number of subjects: 3109

Group type: EXPERIMENTAL
Intervention: ESBL-producing E. coli
Number of subjects: 3109

Group type: EXPERIMENTAL
Intervention: Resistance rates of ESBL-producing E. coli
Number of subjects: 3109
Study: 16978561

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation for 12 weeks and programme maintenance for 24 months
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation for 12 weeks without maintenance programme
Number of subjects: 56

Group type: COMPARATOR
Intervention: Customary care (Control group)
Number of subjects: 56
Study: 12874094

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 11507793

Group type: EXPERIMENTAL
Intervention: Multiple baseline time-series design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interrupted time-series experiments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical analyses of time-series data
Number of subjects: 0
Study: 9191638

Group type: EXPERIMENTAL
Intervention: Bicortical noncompressive screws (S1, n = 15; S2, n = 15)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Unicortical screws and miniplates (P1, n = 15; P2, n = 15)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low-angle cases (ML/NSL < 25 degrees)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Amount of surgical advancement
Number of subjects: 60
Study: 1439646

Group type: EXPERIMENTAL
Intervention: pH‐stat group (with carbon dioxide)
Number of subjects: 12

Group type: COMPARATOR
Intervention: alpha‐stat group (without carbon dioxide)
Number of subjects: 12
Study: 3533674

Group type: EXPERIMENTAL
Intervention: Miraxid (pivmecillinam 200 mg plus pivampicillin 250 mg)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Augmentin (amoxycillin 250 mg plus clavulanic acid 125 mg)
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 388
Study: 31620856

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 30 ml 0.25% bupivacaine
Number of subjects: 56

Group type: COMPARATOR
Intervention: Normal saline as placebo (control group)
Number of subjects: 56
Study: 28514053

Group type: EXPERIMENTAL
Intervention: Theory-guided interventions (Precaution Adoption Process Model or Authoritative Parenting Model)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Conventional dental instruction (CDI)
Number of subjects: 244
Study: 27472452

Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) for SPOV, 12 sessions
Number of subjects: 24

Group type: COMPARATOR
Intervention: Wait list (control group)
Number of subjects: 24
Study: 25296595

Group type: EXPERIMENTAL
Intervention: mFOLFOX7 plus supplementation of tiopronin
Number of subjects: 150

Group type: COMPARATOR
Intervention: mFOLFOX7 without tiopronin (Control)
Number of subjects: 150
Study: 22516357

Group type: EXPERIMENTAL
Intervention: Intravesical 2% chondroitin sulfate (20 mL, 8 weekly instillations)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Inactive control solution (20 mL, 8 weekly instillations)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Intravesical 2% chondroitin sulfate
Number of subjects: 98

Group type: COMPARATOR
Intervention: Inactive control solution
Number of subjects: 98
Study: 20150347

Group type: EXPERIMENTAL
Intervention: 0.5 units oxytocin
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 1 unit oxytocin
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 3 units oxytocin
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 5 units oxytocin
Number of subjects: 75

Group type: COMPARATOR
Intervention: 0 units oxytocin (placebo)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0 units oxytocin
Number of subjects: 75
Study: 17567227

Group type: EXPERIMENTAL
Intervention: Financial incentive group (50% reduction in per-refill copayment)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no financial incentive)
Number of subjects: 200
Study: 16182834

Group type: EXPERIMENTAL
Intervention: Tacrolimus (n = 103)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Cyclosporine ME (n = 102)
Number of subjects: 205
Study: 12517682

Group type: EXPERIMENTAL
Intervention: atenolol 50 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: perindopril 8 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: felodipine 10 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: hydrochlorothiazide 50 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study: 10859584

Group type: EXPERIMENTAL
Intervention: INR self-management
Number of subjects: 600

Group type: COMPARATOR
Intervention: Monitoring by family practitioners
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: INR self-management training
Number of subjects: 600
Study: 9038465

Group type: EXPERIMENTAL
Intervention: Morphine sulphate 10 mg orally pre-operatively
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 1355693

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Diverse neuroleptics
Number of subjects: 223

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 223
Study: 6487753

Group type: EXPERIMENTAL
Intervention: Controlled-release formulation of sodium salicylate (NaSA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enteric-coated tablet of sodium salicylate (NaSA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Solution of sodium salicylate (NaSA)
Number of subjects: 0
Study: 31365457

Group type: EXPERIMENTAL
Intervention: RTF (Repetition to Failure)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: NTF (Not to Failure)
Number of subjects: 18
Study: 30852016

Group type: EXPERIMENTAL
Intervention: Multispecies probiotic bolus (MSP)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo (PLB)
Number of subjects: 148
Study: 29288141

Group type: EXPERIMENTAL
Intervention: Increased number of medications
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Higher depression scores
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Decreased Functional Reach Test (FRT) distance
Number of subjects: 181
Study: 26540737

Group type: EXPERIMENTAL
Intervention: Pilates intervention (36 training sessions over three months, 3 sessions a week)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 88
Study: 24740025

Group type: EXPERIMENTAL
Intervention: CO2 tissue expanders
Number of subjects: 82

Group type: COMPARATOR
Intervention: Saline expanders
Number of subjects: 82
Study: 22302127

Group type: EXPERIMENTAL
Intervention: Oral almorexant 200 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intravenous almorexant 20 mg
Number of subjects: 20
Study: 20571832

Group type: EXPERIMENTAL
Intervention: Bupivacaine (200 mg) with 0.5 mg epinephrine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Levobupivacaine (200 mg) with 0.5 mg epinephrine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bupivacaine and Levobupivacaine
Number of subjects: 60
Study: 17902853

Group type: EXPERIMENTAL
Intervention: Real exposure to EMFs emitted by GSM mobile phones
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham exposure (control)
Number of subjects: 27
Study: 16043829

Group type: EXPERIMENTAL
Intervention: Erlotinib 150 mg/d combined with carboplatin and paclitaxel
Number of subjects: 1059

Group type: COMPARATOR
Intervention: Placebo combined with carboplatin and paclitaxel
Number of subjects: 1059

Group type: EXPERIMENTAL
Intervention: Erlotinib for never smokers
Number of subjects: 1059

Group type: COMPARATOR
Intervention: Placebo for never smokers
Number of subjects: 1059

Group type: COMPARATOR
Intervention: Erlotinib and placebo
Number of subjects: 1059
Study: 12489063

Group type: EXPERIMENTAL
Intervention: diet plus AER (N = 18)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: diet plus LIFE (N = 21)
Number of subjects: 39
Study: 9785782

Group type: EXPERIMENTAL
Intervention: Saline group (n = 15) - received saline 10 ml injected through an epidural catheter 20 min after spinal anesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n = 15) - received 2% lidocaine 3 ml with 0.4% tetracaine injected into the subarachnoid space; saline was not injected into the epidural space
Number of subjects: 30
Study: 8585716

Group type: EXPERIMENTAL
Intervention: Adefovir 1.0 mg/kg intravenous infusion
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Adefovir 3.0 mg/kg intravenous infusion
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Adefovir 1.0 mg/kg/day for 22 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Adefovir 3.0 mg/kg/day for 22 days
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Adefovir 3.0 mg/kg oral dose
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Adefovir 3.0 mg/kg subcutaneous dose
Number of subjects: 28
Study: 2198088

Group type: EXPERIMENTAL
Intervention: Polysaccharide K (PSK)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 216045

Group type: EXPERIMENTAL
Intervention: Amitriptyline treatment
Number of subjects: 6
Study: 31186150

Group type: EXPERIMENTAL
Intervention: ARA‐25 (25 g ARA/100 kcal, no added prebiotic blend)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: PDX/GOS (34 mg ARA/100 kcal, with prebiotic blend)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (34 mg ARA/100 kcal, no added prebiotic blend)
Number of subjects: 80
Study: 25284356

Group type: EXPERIMENTAL
Intervention: Nexplanon® removal
Number of subjects: 0
Study: 23376335

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21729443

Group type: EXPERIMENTAL
Intervention: Cross-over, zigzag neopharyngoplasty (group two)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Pharyngoesophageal myotomy (group one)
Number of subjects: 30
Study: 19774805

Group type: EXPERIMENTAL
Intervention: FMR+TS
Number of subjects: 101

Group type: COMPARATOR
Intervention: FMR
Number of subjects: 101
Study: 16681586

Group type: EXPERIMENTAL
Intervention: Topical 5% 5-FU ointment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo aqueous cream
Number of subjects: 80
Study: 14713798

Group type: EXPERIMENTAL
Intervention: 15 cc 2% lidocaine gel administered intrarectally 10 minutes before biopsy
Number of subjects: 328

Group type: COMPARATOR
Intervention: 10 cc 1% lidocaine under ultrasound guidance as 2 periprostatic injections of 5 cc 5 minutes prior to biopsy
Number of subjects: 328
Study: 11704133

Group type: EXPERIMENTAL
Intervention: Transvaginal hydrolaparoscopy (THL) combined with minihysteroscopy
Number of subjects: 23

Group type: COMPARATOR
Intervention: Hysterosalpingography (HSG)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Transvaginal hydrolaparoscopy (THL)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Minihysteroscopy
Number of subjects: 23
Study: 9863105

Group type: EXPERIMENTAL
Intervention: Ligustrazine (LGT) administered by intravenous drip before occlusion and immediately after release
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 16
Study: 7943837

Group type: COMPARATOR
Intervention: Without isoflurane in a darkened, quiet room
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: At 0.1 MAC isoflurane in a darkened room
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Without isoflurane with audiovisual input
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: At 0.1 MAC isoflurane with audiovisual input
Number of subjects: 10
Study: 3294815

Group type: EXPERIMENTAL
Intervention: trifluoperazine 1 mg b.i.d.
Number of subjects: 54

Group type: COMPARATOR
Intervention: haloperidol 0.5 mg b.i.d.
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: trifluoperazine
Number of subjects: 54

Group type: COMPARATOR
Intervention: haloperidol
Number of subjects: 54
Study: 31081360

Group type: EXPERIMENTAL
Intervention: Red orange juice supplementation (ROJS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 11
Study: 31220936

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 1644

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1644
Study: 27918976

Group type: EXPERIMENTAL
Intervention: Family-oriented program (education classes, group discussions, home visit, telephone follow-up)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Family-oriented program
Number of subjects: 140

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Higher self-management scores
Number of subjects: 140
Study: 25249470

Group type: EXPERIMENTAL
Intervention: Emotion-focused early intervention combining an emotion socialization parenting program with a child and school socio-emotional intervention
Number of subjects: 204

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 204
Study: 23468193

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 102

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 102
Study: 21703531

Group type: EXPERIMENTAL
Intervention: Interval cycle training combined with strength training (40 minutes of interval cycle training + 20 minutes of strength training)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Interval training alone (40 minutes of interval cycle training)
Number of subjects: 28
Study: 19224089

Group type: EXPERIMENTAL
Intervention: Melatonin (9 mg sublingually)
Number of subjects: 71
Study: 16877596

Group type: EXPERIMENTAL
Intervention: Ceramic-on-ceramic total hip replacement
Number of subjects: 28

Group type: COMPARATOR
Intervention: Metal-on-metal total hip replacement
Number of subjects: 28
Study: 15117042

Group type: EXPERIMENTAL
Intervention: ephedrine 70 microg/kg given 1 minute before induction
Number of subjects: 60

Group type: COMPARATOR
Intervention: saline (control group) and midazolam 7.5 mg given orally 30‐60 minutes before induction
Number of subjects: 60
Study: 11281386

Group type: EXPERIMENTAL
Intervention: G-CSF-mobilized peripheral blood stem cell transplantation (BCT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Bone marrow transplantation (BMT)
Number of subjects: 46
Study: 9054279

Group type: EXPERIMENTAL
Intervention: Stavudine
Number of subjects: 822

Group type: COMPARATOR
Intervention: Zidovudine
Number of subjects: 822
Study: 7951550

Group type: EXPERIMENTAL
Intervention: Intensive therapy with insulin and fluid administration
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Diabetic ketoacidosis patients (hyponatremia with hyperkalemia)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Non‐ketotic hyperosmolar coma patients (hyponatremia with hyperkalemia)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Non‐ketotic hyperosmolar coma patients (hypernatremia with hypokalemia)
Number of subjects: 26
Study: 3038494

Group type: EXPERIMENTAL
Intervention: Wheat bran + digoxin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ispaghula + digoxin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study: 29243007

Group type: EXPERIMENTAL
Intervention: Telephone
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Televideo
Number of subjects: 38
Study: 27241991

Group type: EXPERIMENTAL
Intervention: Fluoride varnish treatment once a month for 6 months
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Fluoride film treatment once a month for 6 months
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo treatment (control group)
Number of subjects: 240
Study: 24239143

Group type: EXPERIMENTAL
Intervention: Patient Benefit Index (PBI-L)
Number of subjects: 82
Study: 23793167

Group type: EXPERIMENTAL
Intervention: Er-Xian decoction (EXD)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108